Lin LY - Search Results

1

Selective mechanism-based inactivation of rat CYP2D by 4-allyloxymethamphetamine.

Lin LY, Fujimoto M, Distefano EW, Schmitz DA, Jayasinghe A, Cho AK. Lin LY, et al. J Pharmacol Exp Ther. 1996 May;277(2):595-603. J Pharmacol Exp Ther. 1996. PMID: 8627536

2

Cytochrome P4502D isozymes catalyze the 4-hydroxylation of methamphetamine enantiomers.

Lin LY, Kumagai Y, Hiratsuka A, Narimatsu S, Suzuki T, Funae Y, Distefano EW, Cho AK. Lin LY, et al. Drug Metab Dispos. 1995 Jun;23(6):610-4. Drug Metab Dispos. 1995. PMID: 7587941

3

Inactivation of constitutive hepatic cytochromes P450 by phencyclidine in the rat.

Hiratsuka A, Chu TY, Distefano EW, Lin LY, Schmitz DA, Cho AK. Hiratsuka A, et al. Among authors: lin ly. Drug Metab Dispos. 1995 Feb;23(2):201-6. Drug Metab Dispos. 1995. PMID: 7736912

4

Enzymatic and chemical demethylenation of (methylenedioxy)amphetamine and (methylenedioxy)methamphetamine by rat brain microsomes.

Lin LY, Kumagai Y, Cho AK. Lin LY, et al. Chem Res Toxicol. 1992 May-Jun;5(3):401-6. doi: 10.1021/tx00027a013. Chem Res Toxicol. 1992. PMID: 1354504

5

Regiochemical differences in cytochrome P450 isozymes responsible for the oxidation of methylenedioxyphenyl groups by rabbit liver.

Kumagai Y, Lin LY, Philpot RM, Yamada H, Oguri K, Yoshimura H, Cho AK. Kumagai Y, et al. Among authors: lin ly. Mol Pharmacol. 1992 Oct;42(4):695-702. Mol Pharmacol. 1992. PMID: 1435745

6

Hydroxyl radical mediated demethylenation of (methylenedioxy)phenyl compounds.

Kumagai Y, Lin LY, Schmitz DA, Cho AK. Kumagai Y, et al. Among authors: lin ly. Chem Res Toxicol. 1991 May-Jun;4(3):330-4. doi: 10.1021/tx00021a012. Chem Res Toxicol. 1991. PMID: 1680477

7

Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats.

Kumagai Y, Lin LY, Hiratsuka A, Narimatsu S, Suzuki T, Yamada H, Oguri K, Yoshimura H, Cho AK. Kumagai Y, et al. Among authors: lin ly. Mol Pharmacol. 1994 Feb;45(2):359-65. Mol Pharmacol. 1994. PMID: 7906857

8

The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6).

Tucker GT, Lennard MS, Ellis SW, Woods HF, Cho AK, Lin LY, Hiratsuka A, Schmitz DA, Chu TY. Tucker GT, et al. Among authors: lin ly. Biochem Pharmacol. 1994 Mar 29;47(7):1151-6. doi: 10.1016/0006-2952(94)90386-7. Biochem Pharmacol. 1994. PMID: 7909223

9

Oxidation of methamphetamine and methylenedioxymethamphetamine by CYP2D6.

Lin LY, Di Stefano EW, Schmitz DA, Hsu L, Ellis SW, Lennard MS, Tucker GT, Cho AK. Lin LY, et al. Drug Metab Dispos. 1997 Sep;25(9):1059-64. Drug Metab Dispos. 1997. PMID: 9311621

10

Comparative analysis of mineralocorticoid receptor antagonists and renin-angiotensin system inhibitors/angiotensin receptor neprilysin inhibitor in heart failure with mildly reduced ejection fraction.

Lee CC, Te-Wei Kuan D, Chang KC, Chen ZW, Cheng JF, Lin TT, Lin LY, Wu CK. Lee CC, et al. Among authors: lin ly. Front Pharmacol. 2024 Dec 13;15:1507326. doi: 10.3389/fphar.2024.1507326. eCollection 2024. Front Pharmacol. 2024. PMID: 39734408 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,121 results

Search Page

Filters